Browse Items (5 total)
- Tags: Kaplan-Meier Estimate
Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study
Tags: 2010, 80 And Over, Activities of Daily Living, Aged, Backlog, Canadian Medical Association Journal, Cardiovascular Diseases, Comorbidity, de Craen Anton JM, Depression, Disability Evaluation, Female, Follow-up Studies, Gussekloo J, Hand Strength, Humans, Journal Article, Kaplan-Meier Estimate, Ling CHY, Maier AB, Male, Mortality, Muscle Strength Dynamometer, Netherlands, Neuropsychological Tests, Prospective Studies, Study Design, Taekema D, Westendorp RG
Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma
Tags: 2008, 80 And Over, Adolescent, Adult, Aged, Antineoplastic Agents, Backlog, Boiardi A, Brain Cancer Register of the Fondazione IRCCS (Istituto Ricovero e Cura a Carattere Scientifico) Istituto Neurologico Carlo Besta, Brain Neoplasms, Broggi G, Bruzzone MG, Caldiroli D, Combined Modality Therapy, Disease-Free Survival, Falcone C, Farina R, Farinotti M, Fariselli L, Female, Filippini G, Finocchiaro G, Giombini S, Glioblastoma, Humans, Journal Article, Kaplan-Meier Estimate, Local, Male, Middle Aged, Neoplasm Recurrence, Neuro-oncology, Neurosurgical Procedures, Pollo B, Prognosis, Radiotherapy, Savoiardo M, Solero CL, Treatment Outcome, Valsecchi MG
The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK
Tags: 2008, Adolescent, Adult, Backlog, Child, Connock MJ, Demography, England/epidemiology, Humans, Journal Article, Kaplan-Meier Estimate, Lavery C, Medical, Moore D, Mucopolysaccharidosis I/epidemiology/mortality/physiopathology, Orphanet Journal Of Rare Diseases, Phenotype, Prevalence, Registries, Societies, Wales/epidemiology, Wraith E
Recent trends in cerebral palsy survival. Part II: individual survival prognosis
Tags: 2014, Adolescent, Adult, Backlog, Brooks JC, California, Cerebral Palsy, Child, Developmental Medicine and Child Neurology, Disabled Persons, Female, Humans, Infant, Journal Article, Kaplan-Meier Estimate, Life Expectancy, Male, Mortality, Preschool, Prognosis, Rosenbloom L, Shavelle RM, Strauss DJ, Tran Linh M, Wu YW, Young Adult
R Package for Pediatric Complex Chronic Condition Classification
Tags: 0 (Enzyme Inhibitors), 0 (Lamin Type A), 0 (Piperidines), 0 (prelamin A), 0 (Pyridines), 2018, Adolescent, Adult, Brazier J, Campbell SE, Cause Of Death, Child, Cohort Studies, D'Agostino Sr RB, EC 2.7.4.- (farnesyl phosphate kinase), EC 2.7.4.- (Phosphotransferases (Phosphate Group Acceptor)), Enzyme Inhibitors/therapeutic use, Female, Gordon LB, Humans, IOW153004F (lonafarnib), JAMA., July 2018 List, Kaplan-Meier Estimate, Kieran MW, Kleinman ME, Lamin Type A/biosynthesis/metabolism, Male, Massaro J, Phosphotransferases (Phosphate Group Acceptor)/antagonists & inhibitors, Piperidines/therapeutic use, Post-Translational, Progeria/drug therapy/genetics/mortality, Protein Processing, Pyridines/therapeutic use, Shappell H, Young Adult